STOCK-BASED COMPENSATION (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Restricted Stock Units |
Inputs and assumptions used to calculate the fair value are shown in the table below. The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement. | | | | | | | | | | | | | Nine Months Ended September 30, | 2026 | | 2025 | | Fair value per stock award | $ | 123.35 | | | $ | 154.20 | | | Grant date stock price | $ | 123.97 | | | $ | 147.84 | | | Assumptions: | | | | | Aptar's stock price expected volatility | 19.50 | % | | 17.70 | % | | Expected average volatility of peer companies | 34.60 | % | | 34.10 | % | | Correlation assumption | 24.30 | % | | 31.00 | % | | Risk-free interest rate | 3.79 | % | | 4.03 | % | | Dividend yield assumption | 1.55 | % | | 1.22 | % |
|
| Schedule of Restricted Stock Unit Activity |
A summary of RSU activity as of September 30, 2026 and changes during the nine month period then ended is presented below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Time-Based RSUs | | Performance-Based RSUs | | Units | | Weighted Average Grant-Date Fair Value | | Units | | Weighted Average Grant-Date Fair Value | | Nonvested at January 1, 2026 | 215,433 | | | $ | 135.89 | | | 434,878 | | | $ | 135.31 | | | Granted | 146,343 | | | 120.23 | | | 229,998 | | | 120.95 | | | Vested | (106,420) | | | 131.10 | | | (198,125) | | | 116.17 | | | Forfeited | (6,901) | | | 131.80 | | | (47,235) | | | 111.46 | | | Nonvested at September 30, 2026 | 248,455 | | | $ | 128.67 | | | 419,516 | | | $ | 139.16 | |
|
| Schedule of Compensation Expense, Fair Value, and Intrinsic Value Related to Rsu's |
| | | | | | | | | | | | | Nine Months Ended September 30, | 2026 | | 2025 | | Compensation expense (included in SG&A) | $ | 23,902 | | | $ | 27,515 | | | Compensation expense (included in Cost of sales) | 2,269 | | | 2,588 | | | Compensation expense, Total | $ | 26,171 | | | $ | 30,103 | | | Fair value of units vested | 35,358 | | | 43,382 | | | Intrinsic value of units vested | 37,772 | | | 53,743 | |
|
| Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: | | | | | | | | | | | | | Stock Award Plans: | | | | | Nine Months Ended September 30, | 2026 | | 2025 | | Dividend Yield | 1.40 | % | | 1.17 | % | | Expected Stock Price Volatility | 19.72 | % | | 17.66 | % | | Risk-free Interest Rate | 4.06 | % | | 4.21 | % | | Expected Life of Option (years) | 7.0 | | 7.0 |
|
| Schedule of Option Activity |
A summary of option activity under our stock plans during the nine months ended September 30, 2026 is presented below: | | | | | | | | | | | | | | | | | | | | | | | | | Stock Awards Plans | | | | Options | | Weighted Average Exercise Price | | | | | | Outstanding, January 1, 2026 | 1,608,498 | | | $ | 103.45 | | | | | | | Granted | 283,326 | | | 124.20 | | | | | | | Exercised | (298,136) | | | 75.01 | | | | | | | Forfeited or expired | (9,813) | | | 123.47 | | | | | | | Outstanding at September 30, 2026 | 1,583,875 | | | $ | 112.39 | | | | | | | Exercisable at September 30, 2026 | 1,081,669 | | | $ | 102.61 | | | | | | | Weighted-Average Remaining Contractual Term (Years): | | | | | | | | | Outstanding at September 30, 2026 | 5.3 | | | | | | | | Exercisable at September 30, 2026 | 3.6 | | | | | | | | Aggregate Intrinsic Value: | | | | | | | | | Outstanding at September 30, 2026 | $ | 26,744 | | | | | | | | | Exercisable at September 30, 2026 | $ | 26,744 | | | | | | | | Intrinsic Value of Options Exercised During the Nine Months Ended: | | | | | | | | | September 30, 2026 | $ | 15,962 | | | | | | | | | September 30, 2025 | $ | 15,079 | | | | | | | |
|
| Schedule of Compensation Expense, and Fair Value Related to Options |
| | | | | | | | | | | | | Nine Months Ended September 30, | 2026 | | 2025 | | Compensation expense (included in SG&A) | $ | 6,305 | | | $ | 6,082 | | | Compensation expense (included in Cost of sales) | 567 | | | 587 | | | Compensation expense, Total | $ | 6,872 | | | $ | 6,669 | | | Compensation expense, net of tax | 5,776 | | | 5,455 | | | Grant date fair value of options vested | 7,502 | | | 5,200 | |
|